8:22 AM
Leo Group India
| ||
| Pharmaceutical products scandal rocks Lebanon amid political tension NOW LEBANON A scandal pertaining to illegal pharmaceutical products was uncovered in Lebanon earlier this week amid reports that the brother of Minister of State for Administrative Reform Mohammad Fneish is involved in the case. Also, some media outlets reported ... See all stories on this topic » | ||
| Orchid Chemicals to exit Chinese joint venture The Hindu The 50 per cent stake that Orchid holds in the joint venture company, NCPC-Orchid Pharmaceuticals, will be transferred to the partner company, North China Pharmaceutical Corporation (NCPC), for a cash of $13.9 million (RMB 87.5 million), according to a ... See all stories on this topic » | ||
| ||
| SciClone Pharmaceuticals Management Discusses Q3 2012 Results - Earnings ... Seeking Alpha The acquisition of NovaMed was a major strategic event that transformed our company and established SciClone as a substantial specialty pharmaceutical company in the China market with broad market presence and significant growth prospects. Almost ... See all stories on this topic » | ||
| Immune Pharma and EpiCept enter merger agreement pharmabiz.com Immune Pharmaceuticals Ltd. (Immune), a privately held Israeli company, and EpiCept Corporation (EpiCept), a company focused on the development and commercialization of pharmaceutical products for the treatment of pain and cancer, have entered into a ... See all stories on this topic » | ||
| The pharmaceutical giant was stripped of its patent, leaving room for generic ... Salon Pfizer, inventors of Viagra, on Thursday lost their patent to the erectile dysfunction drug in Canada. The Canadian Supreme Court justices unanimously decided to end the pharmaceutical giant's monopoly over the drug, which — under patent law — should ... See all stories on this topic » | ||
| ||
| 4 Pharmaceutical Stocks to Buy Now Investorplace.com Four Pharmaceutical stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy"). Novartis (NYSE:NVS) is making progress this week as its ... See all stories on this topic » | ||
| Buy, Sell, or Hold: Spectrum Pharmaceuticals Motley Fool Spectrum Pharmaceuticals, with a market cap near $650 million, was founded in 1987 and is based in Nevada. It's a biotechnology company, focusing mainly on hematology and oncology drugs. Before 2002, you may have known it as NeoTherapeutics. See all stories on this topic » | ||
| Buy Cipla - Fairwealth Institutional Research Equity Bulls Chemical, Industrial & Pharmaceutical Laboratories (CIPLA) was incorporated in 1935 by Khwaza Abdul Hameid. The company focuses on development of new formulations and has a wide range of pharmaceutical products such as prescription drugs, bulk ... See all stories on this topic » |
This once a day Google Alert is brought to you by Google.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment